HKEX: 6821 - Asymchem Laboratories (Tianjin) Co., Ltd.

Yield per half year: +13.55%
Sector: Healthcare

Asymchem Laboratories (Tianjin) Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.98 35.42 -63.36% 44.91 -71.11%
P/S 3.76 7.59 -50.42%
P/BV 1.68 3.68 -54.37%
P/FCF 21.91 55.3 -60.39%
Ev/Ebitda 10.74 2.91 269.34%
Ev/S 5.32 23.72 -77.58%
Ev/FCF 18.02 63.78 -71.74%
E/P 0.0449 0.0326 37.6%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
39.85 -11.9 -434.83% 32.99 +20.79%
ROE 13.7 5.19 164.1%
ROA 11.94 3.47 244.11%
ROIC 0 0 0%
ROS 28.99 -11.49 -352.37%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.033 0.7755 -95.74% 0.0867 -61.94%
Nеt Debt/Ebitda 0 0.0127 -100%
Debt/Ratio 0.0068 0.1229 -94.45%
Debt/Equity 0.0251 0.776 -96.77%
Debt/Net Income 0.0594 1.76 -96.62%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
4.41 5.7 -22.63% 2.35 +87.9%
Number of years of dividend growth 2 1.13 77.78%
DSI 0.875 0.5838 49.88%
Average dividend growth 32.99 3.2 929.96%
Average percentage for 5 years 2.35 4.95 -52.61%
Average percentage for payments 16.45 23.96 -31.35%
Difference from average difference in sector -1.29

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
219.94 28.69 666.61%
Growth impulse Ebitda in 5 years 446.11 -40.52 -1200.96%
Growth impulse Net Income in 5 years 311.32 94.84 228.26%
Growth impulse FCF in 5 years 2461.28 91.41 2592.57%
Growth impulse EPS in 5 years 309.18 -118.14 -361.71%
IP Score
7.48/10

Similar companies

Hangzhou Tigermed Consulting Co., Ltd

Livzon Pharmaceutical Group Inc.

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription